Newsletter – January 31st 2023

NEWSLETTER: What’s New In 2023: ExcitingPlans For Upperton Pharma Solutions! The New Year is always a time for looking ahead and 2023 will no doubt turn out to be a pivotal year in the Upperton Pharma Solutions growth story. In this Newsletter we will be previewing some of the exciting new plans that we have … Read more

New Job Opportunity – Senior QC Scientist/Senior Analytical Co-Ordinator

Senior QC Scientist/Senior Analytical Co-Ordinator
Upperton Pharma Solutions is a Nottingham-based CDMO that specialises in the formulation and spray drying of pharmaceutical and biotechnology products, providing a complete service from early-stage feasibility through to development and scale-up (including GMP clinical manufacture). Formulations cover a range of delivery routes, typically including oral (tablets & capsules), nasal and inhaled.

The Upperton laboratories and manufacturing plant are situated on the Science Park, adjacent to the University of Nottingham, and since obtaining an MHRA clinical trials manufacturing licence in 2019 we have experienced rapid, continuous growth across the whole business to continually satisfy our growing, international customer base.

As part of this expansion programme Upperton is looking to recruit a Senior Analytical Co-ordinator to join our Analytical Team.

18th January 2023 Upperton Pharma Solutions breaks ground on new Nottingham based development and manufacturing facility

Upperton Pharma Solutions breaks ground on new Nottingham based development and manufacturing facilityNottingham : 18th January 2023 Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has begun construction work for its new Development and GMP Manufacturing headquarters in Nottingham, UK. Working in close collaboration with … Read more

Newsletter – December 21st 2022

NEWSLETTER: Seasons Greetings To All Of Our Customers Traditionally at this time of year we like to offer Season’s Greetings to all our customers and friends and whilst doing so, look back over the years at some of the highlights in what has been an exceptionally busy (and successful) year for Upperton Pharma Solutions! Here … Read more

29th November 2022 Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility

29th November 2022 – Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has appointed T-SQUARED, … Read more

Newsletter – November 16th 2022

Upperton Launches ASAPprime® Shelf-Life Stability Testing Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients state of the art stability testing. This exciting new platform can be used to generate robust, accelerated chemical stability data and is now being applied at all stages of the … Read more

New Job Opportunity – Senior Quality Assurance Officer

Senior Quality Assurance Officer
Upperton Pharma Solutions is a pharmaceutical company based at the Science and Technology Park close to Nottingham University. Due to continuing expansion, an exciting opportunity has arisen for Quality Assurance Officer.

The Role
Working as a Senior Quality Assurance Officer, primarily within a small team in the GMP Quality department. The role will be varied, using various tools to address and coach Change Control, Deviations, OOS and CAPA.

Newsletter – September 15th 2022

In Vitro Testing of Dry Powder Nasal Delivery Devices Successful nasal drug delivery of dry powder formulations requires a delivered dose that can penetrate beyond the nasal entrance region and deposit in the peripheral nasal cavity, whilst avoiding deeper penetration to the airways of the lungs. This delivery, or deposition pattern, is determined by the … Read more

Newsletter – August 16th 2022

Latest News from Upperton Pharma Solutions Successful MHRA Inspection Upperton is delighted to announce that during the last week of July 2022 the UK MHRA conducted a routine, three day inspection of the GMP facility and Quality Control testing laboratories following which, no Critical or Major observations were raised. Speaking after the inspection, CEO Nikki … Read more

Newsletter – June 23rd 2022

Characterising the physical properties of spray dried powders The benefits of powder characterisation When developing products containing spray dried powders it is vital that the physical properties of the powders produced are determined. The physical properties of spray dried powders provides important information that can assist during the pre-formulation screening and early process development phases … Read more